Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse
- PMID: 3294069
- DOI: 10.1007/BF00277415
Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse
Abstract
The predictive value of insulitis, islet cell cytoplasmic antibodies and insulin autoantibodies for insulin-dependent diabetes was studied in young female non-obese diabetic mice. The ontogeny of the three markers was examined cross-sectionally at days 15, 25, 40 and 90 while islet cell antibodies and insulin autoantibodies were studied longitudinally from day 35 or day 144-168 until approximately day 250. Insulitis was first observed at day 40 (50%) and subsequently at day 90 (70%). Islet cell antibodies and insulin autoantibodies were present at day 15 in 46% and 54% of the animals respectively. The rate of islet cell antibodies was slightly higher at day 25 (60%) than at day 40 (40%) and day 90 (54%) whereas antibodies to insulin were present in all samples from day 25-90. At day 40 and day 90 insulitis and insulin autoantibodies were present together in 42% and 70% of the animals, respectively, while insulitis and islet cell antibodies had a lower rate of concordance (17% and 42%, respectively; diabetes rate, 30%). The concordance rates for islet cell antibodies and insulin autoantibodies were 42% at day 40 and 54% at day 90. Concordance for all three markers was first observed at day 40 (17%) which increased to 38% at day 90. In longitudinal studies, islet cell antibodies and insulin autoantibodies were often present together whether or not diabetes supervened. In the islet cell antibody procedure, immunoreactive cells were shown immunohistochemically to correspond with insulin and/or glucagon cells. However, this staining was not suppressible with insulin- or glucagon- absorbed sera, implying the presence of non-hormonal autoantigens. We conclude that the three markers investigated are expressed early after birth and well before clinical symptoms appear in this animal model. Both islet cell antibodies and insulin autoantibodies preceded insulitis but the prevalence rate for each marker or their degree of concordance was different from the anticipated rate of diabetes in our colony. Consequently, the early expression of the three markers alone is not predictive of diabetes although concordance for the two, or all three markers may be of some value. However, no animal developed diabetes without the prior appearance of both islet cell antibodies and insulin autoantibodies.
Similar articles
-
First phase insulin release in the non-obese diabetic mouse: correlation with insulitis, beta cell number and autoantibodies.Diabetes Res Clin Pract. 1992 Jul;17(1):17-25. doi: 10.1016/0168-8227(92)90039-t. Diabetes Res Clin Pract. 1992. PMID: 1511657
-
Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study.Diabetologia. 1987 May;30(5):292-7. doi: 10.1007/BF00299020. Diabetologia. 1987. PMID: 3301480
-
Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.Clin Immunol Immunopathol. 1989 Jan;50(1 Pt 2):S85-95. doi: 10.1016/0090-1229(89)90115-3. Clin Immunol Immunopathol. 1989. PMID: 2642771 Review.
-
Insulin autoantibodies in mouse models of insulin-dependent diabetes.Diabetes Res. 1989 Jun;11(2):61-5. Diabetes Res. 1989. PMID: 2620486
-
Initiation of autoimmune type 1 diabetes and molecular cloning of a gene encoding for islet cell-specific 37kd autoantigen.Adv Exp Med Biol. 1994;347:207-20. doi: 10.1007/978-1-4615-2427-4_18. Adv Exp Med Biol. 1994. PMID: 7976732 Review.
Cited by
-
The role of the intestinal microbiota in type 1 diabetes mellitus.Nat Rev Endocrinol. 2016 Mar;12(3):154-67. doi: 10.1038/nrendo.2015.218. Epub 2016 Jan 4. Nat Rev Endocrinol. 2016. PMID: 26729037 Review.
-
Longitudinal study of islet cell antibodies and insulin autoantibodies and development of diabetes in non-obese diabetic (NOD) mice.Clin Exp Immunol. 1990 Sep;81(3):400-5. doi: 10.1111/j.1365-2249.1990.tb05346.x. Clin Exp Immunol. 1990. PMID: 2204503 Free PMC article.
-
Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope.J Exp Med. 2011 Jul 4;208(7):1501-10. doi: 10.1084/jem.20110574. Epub 2011 Jun 20. J Exp Med. 2011. PMID: 21690251 Free PMC article.
-
Insulin as a target antigen in autoimmune diabetes: a natural repertoire as the source of antibody response.Acta Diabetol. 1994 Jun;31(2):66-72. doi: 10.1007/BF00570537. Acta Diabetol. 1994. PMID: 7949224
-
Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: a light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration.Histochem J. 1997 Jan;29(1):53-64. doi: 10.1023/a:1026416918339. Histochem J. 1997. PMID: 9088945
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical